Skip to main content
MAYNE PHARMA GROUP LIMITED logo

MAYNE PHARMA GROUP LIMITED — Investor Relations & Filings

Ticker · MYX ISIN · AU000000MYX0 LEI · 549300VIRDEN0N4MJG59 ASX Manufacturing
Open in API
Filings indexed 1,118 across all filing types
Latest filing 2023-11-09 Transaction in Own Shar…
Country AU Australia
Listing ASX MYX

About MAYNE PHARMA GROUP LIMITED

https://www.maynepharma.com

Mayne Pharma Group Limited is a specialty pharmaceutical company focused on the development and commercialization of branded and generic medicines. The company operates through specialized segments including Women's Health and Dermatology. Its Women's Health portfolio features innovative contraceptive solutions, while the Dermatology division provides a broad range of treatments for various skin conditions. Beyond its product portfolio, the company provides contract development and manufacturing services (CDMO), leveraging proprietary drug delivery technologies to produce complex oral and topical dosage forms. The organization focuses on high-growth specialty markets, aiming to deliver differentiated therapeutic options and improve patient outcomes through technical excellence and strategic commercialization.

Recent filings

Filing Released Lang Actions
Update - Notification of buy-back - MYX 6 pages 27.7KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Notification of buy-back' and contains detailed information about an on-market share buy-back program by Mayne Pharma Group Limited. It includes specifics such as the number of securities bought back, dates, prices paid, broker details, and regulatory compliance references (e.g., ASX listing rules). The content is focused on reporting daily updates of the company's share repurchase activity rather than financial results, management changes, or other report types. This matches the definition of a 'Transaction in Own Shares' filing, which reports the company's buyback of its own shares. The document length and detail confirm it is not a brief announcement or a report publication notice but a substantive update on share repurchase transactions.
2023-11-09 English
Update - Notification of buy-back - MYX 6 pages 27.7KB
Transaction in Own Shares Classification · 100% confidence The document is a detailed notification about a company's share buy-back activity, including daily updates on the number of shares bought back, prices paid, broker information, and regulatory compliance details. It specifically mentions 'Notification of buy-back' and 'Daily buy-back notification' multiple times, indicating it is a report on the company's repurchase of its own shares. This matches the definition of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares. The document is not an announcement of a report, nor is it a financial report or regulatory filing. Therefore, the correct classification is POS with high confidence.
2023-11-08 English
Update - Notification of buy-back - MYX 6 pages 27.7KB
Transaction in Own Shares Classification · 100% confidence The document is a detailed notification of a buy-back by Mayne Pharma Group Limited. It includes specifics such as the type of buy-back (on-market), dates, number of securities bought back, prices paid, broker information, and compliance with listing rules. The content is focused on the company's share repurchase activity rather than financial results, management changes, or regulatory filings. The presence of daily buy-back notifications and detailed buy-back data clearly indicates this is a Transaction in Own Shares report.
2023-11-07 English
Update - Notification of buy-back - MYX 6 pages 27.7KB
Transaction in Own Shares Classification · 100% confidence The document is a detailed notification of a daily buy-back of shares by Mayne Pharma Group Limited. It includes specifics such as the number of securities bought back, prices paid, dates, broker information, and regulatory compliance references (e.g., ASX listing rules). The content is focused on the company's share repurchase activity rather than financial results, management changes, or other report types. This matches the definition of a Transaction in Own Shares (POS) filing, which reports on the company's buyback of its own shares. The document length and detail confirm it is not a brief announcement or a report publication notice but the actual notification of buy-back activity.
2023-11-06 English
Issuance of additional US Patent for NEXTSTELLIS 2 pages 131.0KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement regarding the issuance of an additional US patent for the pharmaceutical product NEXTSTELLIS®. It discusses patent details, patent expiration, and strategic importance of the patent to the company. There are no financial statements, earnings data, or management discussion of financial results. The document is a corporate announcement about intellectual property and patent protection, not a financial report or regulatory filing related to financial performance or governance changes. It is also not a report publication announcement or certification. Therefore, the most appropriate classification is a Regulatory Filing (RNS), as it is a general regulatory announcement that does not fit into other specific categories.
2023-11-05 English
Ceasing to be a substantial holder 39 pages 2.3MB
Major Shareholding Notification Classification · 100% confidence The document is an ASX Form 605 titled 'Notice of ceasing to be a substantial shareholder' under the Corporations Act 2001 Section 671B. It details changes in relevant interests of a substantial holder, including dates, nature of changes, and securities affected. The document is a regulatory notice about shareholding changes, specifically about ceasing to be a substantial shareholder. It is not a financial report, earnings release, or management report. It fits the definition of a Major Shareholding Notification, which involves notification of changes in significant share ownership levels crossing thresholds. The document length is substantial and contains detailed transaction data, consistent with a Major Shareholding Notification filing.
2023-11-02 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.